Handelsbanken Fonder’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5M Buy
332,176
+18,816
+6% +$1.65M 0.09% 199
2026
Q1
$26.7M Buy
313,360
+5,620
+2% +$501K 0.09% 190
2025
Q4
$24.3M Sell
307,740
-13,946
-4% -$1.09M 0.07% 229
2025
Q3
$25.7M Sell
321,686
-30,750
-9% -$2.62M 0.08% 219
2025
Q2
$32M Buy
352,436
+31,825
+10% +$2.91M 0.11% 170
2025
Q1
$30M Sell
320,611
-1,711
-0.5% -$153K 0.12% 164
2024
Q4
$29.3M Sell
322,322
-10,650
-3% -$1.02M 0.11% 170
2024
Q3
$34.6M Buy
332,972
+32,624
+11% +$3.33M 0.14% 151
2024
Q2
$29.1M Sell
300,348
-68,712
-19% -$6.34M 0.13% 163
2024
Q1
$33.2M Sell
369,060
-45,776
-11% -$3.88M 0.14% 157
2023
Q4
$33.1M Buy
414,836
+5,498
+1% +$413K 0.16% 149
2023
Q3
$29.1M Buy
409,338
+3,233
+0.8% +$242K 0.16% 143
2023
Q2
$31.3M Sell
406,105
-4,440
-1% -$344K 0.17% 141
2023
Q1
$30.9M Buy
410,545
+31,723
+8% +$2.36M 0.18% 139
2022
Q4
$29.8M Buy
378,822
+37,123
+11% +$2.78M 0.19% 127
2022
Q3
$24M Buy
341,699
+38,058
+13% +$2.98M 0.16% 156
2022
Q2
$24.3M Buy
303,641
+44,497
+17% +$3.48M 0.16% 149
2022
Q1
$19.7M Sell
259,144
-1,137
-0.4% -$90.1K 0.11% 198
2021
Q4
$22.2M Sell
260,281
-521
-0.2% -$40.7K 0.11% 196
2021
Q3
$19.7M Buy
260,802
+1,053
+0.4% +$83.6K 0.1% 205
2021
Q2
$21.1M Sell
259,749
-1,357
-0.5% -$111K 0.11% 197
2021
Q1
$20.6M Buy
261,106
+55,773
+27% +$4.37M 0.12% 178
2020
Q4
$17.6M Buy
205,333
+5,361
+3% +$443K 0.11% 195
2020
Q3
$15.4M Buy
199,972
+5,200
+3% +$396K 0.11% 190
2020
Q2
$14.3M Buy
+194,772
New +$13.8M 0.12% 167
2017
Q2
Sell
-85,000
Closed -$6.22M 171
2017
Q1
$6.22M Sell
85,000
-434,000
-84% -$30.4M 0.17% 106
2016
Q4
$34M Sell
519,000
-25,000
-5% -$1.71M 1.04% 31
2016
Q3
$40.3M Sell
544,000
-5,478
-1% -$405K 1.18% 25
2016
Q2
$40.2M Hold
549,478
1.65% 13
2016
Q1
$38.8M Sell
549,478
-93,704
-15% -$6.23M 1.66% 16
2015
Q4
$42.8M Buy
+643,182
New +$42.8M 0.83% 22

Other funds holding CL

Handelsbanken Fonder's CL Position: Q2 2026 in Review

Handelsbanken Fonder increased its Colgate-Palmolive (CL) stake by 6% in Q2 2026, buying an estimated $1.65M and bringing the position to 332,176 shares worth $30.5M. The position accounts for 0.09% of the portfolio, ranked #199.

Handelsbanken Fonder first reported a position in CL in Q4 2015 and has held it in 31 quarters since. The position peaked at $42.8M in Q4 2015. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Handelsbanken Fonder held 332,176 shares of Colgate-Palmolive worth $30.5M as of Q2 2026.
  • Handelsbanken Fonder bought 18,816 Colgate-Palmolive shares in Q2 2026, an estimated $1.65M.
  • Colgate-Palmolive made up 0.09% of Handelsbanken Fonder's portfolio in Q2 2026, its #199 holding.
  • Handelsbanken Fonder first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 31 quarters since.
  • Handelsbanken Fonder's Colgate-Palmolive position peaked at $42.8M in Q4 2015.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.